MCRB Next Earnings Date Notes

— Seres Therapeutics (“MCRB”) is a biotechnology company pioneering microbiome therapeutics, with a primary focus on developing novel, ecologically designed bacterial consortia to treat diseases impacted by the human microbiome. The company's most advanced product is VOWST (fecal microbiota spores, live), which has received FDA approval for reducing recurrence of Clostridioides difficile infection (“C. diff”) in adults, marking a significant achievement as the first oral microbiome therapy approved in the U.S. For investors, the most crucial business metrics to track are VOWST's commercial sales figures, prescription and adoption rates, royalty and collaboration revenue (especially from partnership with Nestlé Health Science), the pace of patient uptake, and cash runway/burn rate as they scale commercialization. Progress in pipeline development for other indications using the company's microbiome platform is also key to long-term growth. On the next earnings call, attention should be paid to updates on VOWST's market performance, progress in expanding payer coverage, any regulatory milestones for new indications, and Seres' strategic priorities for advancing additional investigational microbiome therapeutics. The next projected earnings date for MCRB is 11/4/2026 7:00 am (stay tuned for a confirmed earnings date once announced).

MCRB Next Earnings Date FAQ

On this page we presented the MCRB Next Earnings Date information for Seres Therapeutics along with recent past earnings dates. For Q2 of 2026, MCRB reported earnings of 0.470/share, with the earnings report taking place on 8/5/2026. For Q1 of 2026, MCRB reported earnings of -2.080/share, with the earnings report taking place on 5/5/2026. For Q4 of 2025, MCRB reported earnings of -1.760/share, with the earnings report taking place on 3/12/2026. For Q3 of 2025, MCRB reported earnings of 0.940/share, with the earnings report taking place on 11/5/2025. For Q2 of 2025, MCRB reported earnings of -2.270/share, with the earnings report taking place on 8/6/2025. Based on these past earnings dates, the projected next earnings date for MCRB is 11/4/2026 7:00 am.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Seres Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Seres Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Seres Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next MCRB earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up MCRB's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the MCRB next earnings date.